POLYBUTYRATE Trademark

Trademark Overview


On Monday, November 14, 2016, a trademark application was filed for POLYBUTYRATE with the United States Patent and Trademark Office. The USPTO has given the POLYBUTYRATE trademark a serial number of 87235350. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, August 13, 2018. This trademark is owned by Tesseract Medical Research, LLC. The POLYBUTYRATE trademark is filed in the Pharmaceutical Products category with the following description:

Dietary supplements; nutritional supplements; medical foods, namely, medical food supplements and dietetic food supplements, both containing short-chain fatty acids in single molecule form with a release agent that enhances solubility and absorption; nutritional ingredients, namely, a blend of nutrients, namely, short-chain fatty acids in single molecule form with a release agent that ensures solubility and absorption, that are an integral component of medicals foods, for short-chain fatty acid deficiencies in individuals with Autism Spectrum Disorder; nutraceuticals for use as dietary supplements and nutritional supplements; vitamin preparations and mineral preparations to mitigate short-chain fatty acid microbiome deficiencies in individuals with Autism Spectrum Disorder; dietary supplements for restoring health in individuals with diseases, disorders, nutritional deficiencies, and adverse health conditions; therapeutic agents for human medical, medicinal, and therapeutic purposes, n...
polybutyrate

General Information


Serial Number87235350
Word MarkPOLYBUTYRATE
Filing DateMonday, November 14, 2016
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, August 13, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesDietary supplements; nutritional supplements; medical foods, namely, medical food supplements and dietetic food supplements, both containing short-chain fatty acids in single molecule form with a release agent that enhances solubility and absorption; nutritional ingredients, namely, a blend of nutrients, namely, short-chain fatty acids in single molecule form with a release agent that ensures solubility and absorption, that are an integral component of medicals foods, for short-chain fatty acid deficiencies in individuals with Autism Spectrum Disorder; nutraceuticals for use as dietary supplements and nutritional supplements; vitamin preparations and mineral preparations to mitigate short-chain fatty acid microbiome deficiencies in individuals with Autism Spectrum Disorder; dietary supplements for restoring health in individuals with diseases, disorders, nutritional deficiencies, and adverse health conditions; therapeutic agents for human medical, medicinal, and therapeutic purposes, namely, increasing butyric acid in the gastrointestinal tract; functional nutrients containing butyric acid and acetic acid to mitigate short-chain fatty acid gut microbiome deficiencies in individuals with Autism Spectrum Disorder; pharmaceutical preparations to mitigate short-chain fatty acid gut microbiome deficiencies in individuals with Autism Spectrum Disorder; specialty nutraceuticals for the dietary management of diseases, disorders, and nutritional deficiencies, namely, short-chain fatty acid gut microbiome deficiencies in individuals with Autism Spectrum Disorder and deficiencies of butyrate in the gastrointestinal tract

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, November 18, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTesseract Medical Research, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNapa, CA 94558

Trademark Events


Event DateEvent Description
Monday, August 13, 2018ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, August 13, 2018ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, January 5, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, January 5, 2018NON-FINAL ACTION E-MAILED
Friday, January 5, 2018NON-FINAL ACTION WRITTEN
Thursday, December 28, 2017PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, August 1, 2017WITHDRAWN FROM PUB - OG REVIEW QUERY
Thursday, July 20, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, July 19, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 19, 2017EXAMINER'S AMENDMENT ENTERED
Wednesday, July 19, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, July 19, 2017EXAMINERS AMENDMENT E-MAILED
Wednesday, July 19, 2017EXAMINERS AMENDMENT -WRITTEN
Wednesday, July 19, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 19, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 19, 2017ASSIGNED TO LIE
Friday, June 23, 2017TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, May 15, 2017NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, May 15, 2017FINAL REFUSAL E-MAILED
Monday, May 15, 2017FINAL REFUSAL WRITTEN
Saturday, April 29, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 28, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 28, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 11, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 11, 2017NON-FINAL ACTION E-MAILED
Tuesday, April 11, 2017NON-FINAL ACTION WRITTEN
Friday, March 31, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 30, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 30, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 21, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 21, 2017NON-FINAL ACTION E-MAILED
Tuesday, February 21, 2017NON-FINAL ACTION WRITTEN
Tuesday, February 21, 2017ASSIGNED TO EXAMINER
Friday, November 18, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, November 17, 2016NEW APPLICATION ENTERED IN TRAM